Iranian
Biomedical Journal
Volume 28, Issue 4 (7-2024)
IBJ 2024, 28(4): 192-205 |
Back to browse issues page
Ethics code: IR.ZUMS.REC.399.203
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Pourmansouri Z, Malekkhatabi A, Toolabi M, Akbari M, Shahbazi M A, Rostami* A. Anti-Nociceptive Effect of Sufentanil Polymeric Dissolving Microneedle on Male Mice by Hot Plate Technique. IBJ 2024; 28 (4) :192-205
URL: http://ibj.pasteur.ac.ir/article-1-4062-en.html
URL: http://ibj.pasteur.ac.ir/article-1-4062-en.html
Zeinab Pourmansouri 
, Atefeh Malekkhatabi , Maryam Toolabi , Mahsa Akbari , Mohammad Ali Shahbazi * , Ali Rostami*
, Atefeh Malekkhatabi , Maryam Toolabi , Mahsa Akbari , Mohammad Ali Shahbazi * , Ali Rostami*
Abstract:
Background: Despite the widespread use of opioids to manage severe pain, its systemic administration results in side effects. Among the subcutaneous and transdermal drug delivery systems developed to deal with adverse effects, microneedles have drawn attention due to their rapid action, high drug bioavailability, and improved permeability. Sufentanil (SUF) is an effective injectable opioid for treating severe pain. In this study, we investigated the analgesic effects of SUF using dissolvable microneedles.
Methods: SUF polymeric dissolvable microneedles were constructed through the mold casting method and characterized by SEM and FTIR analysis. Its mechanical strength was also investigated using a texture analyzer. Fluorescence microscopy was applied in vitro to measure the penetration depth of microneedle arrays. Irritation and microchannel closure time, drug release profile, and hemocompatibility test were conducted for the validation of microneedle efficiency. Hot plate test was also used to investigate the analgesic effect of microneedle in an animal model.
Results: Local administration of SUF via dissolving microneedles had an effective analgesic impact. One hour after administration, there was no significant difference between the subcutaneous and the microneedle groups, and the mechanical properties were within acceptable limits.
Conclusion: Microneedling is an effective strategy in immediate pain relief compared to the traditional methods.
Methods: SUF polymeric dissolvable microneedles were constructed through the mold casting method and characterized by SEM and FTIR analysis. Its mechanical strength was also investigated using a texture analyzer. Fluorescence microscopy was applied in vitro to measure the penetration depth of microneedle arrays. Irritation and microchannel closure time, drug release profile, and hemocompatibility test were conducted for the validation of microneedle efficiency. Hot plate test was also used to investigate the analgesic effect of microneedle in an animal model.
Results: Local administration of SUF via dissolving microneedles had an effective analgesic impact. One hour after administration, there was no significant difference between the subcutaneous and the microneedle groups, and the mechanical properties were within acceptable limits.
Conclusion: Microneedling is an effective strategy in immediate pain relief compared to the traditional methods.
Type of Study: Full Length/Original Article |
Subject:
Pharmaceutical Biotechnology
References
1. Merskey HJP. Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain. 1979; 6:249-52.
2. Kerrigan S, Goldberger BA. Opioids. Principles of forensic toxicology. first ed: Springer; 2020. p. 347-69. [DOI:10.1007/978-3-030-42917-1_22]
3. Maurya A, Rangappa S, Bae J, Dhawan T, Ajjarapu SS, Murthy SN. Evaluation of soluble fentanyl microneedles for loco-regional anti-nociceptive activity. Int J Pharm. 2019; 564:485-91. [DOI:10.1016/j.ijpharm.2019.04.066]
4. Porela-Tiihonen S, Kokki H, Kokki MJEOoP. An up-to-date overview of sublingual sufentanil for the treatment of moderate to severe pain. Expert Opin Pharmacother. 2020; 21(12):1407-18. [DOI:10.1080/14656566.2020.1766025]
5. Wang Y, Xu W, Xia W, Wei L, Yang D, Deng X, et al. Comparison of the Sedative and Analgesic Effects of dexmedetomidine-remifentanil and dexmedetomidine -dufentanil for liposuction: A prospective single-blind Randomized Controlled Study. Aesthetic Plast Surg. 2022; 46(1):524-34. [DOI:10.1007/s00266-021-02566-z]
6. Sridharan K, Sivaramakrishnan GJCcp. Comparison of fentanyl, remifentanil, sufentanil and alfentanil in combination with propofol for general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Curr Clin Pharmacol. 2019; 14(2):116-24. [DOI:10.2174/1567201816666190313160438]
7. Fang P, Qian J, Ding J, Pan X, Su H, Liu XJP, et al. Comparison of analgesic effects between nalbuphine and sufentanil in first-trimester surgical abortion: a randomized, double-blind, controlled trial. Pain Ther. 2022; 11(1):121-32. [DOI:10.1007/s40122-021-00334-0]
8. Van de Donk T, Ward S, Langford R, Dahan AJA. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management. Anaesthesia. 2018; 73(2):231-7. [DOI:10.1111/anae.14132]
9. Zhao L, Li YJOL. Application of dexmedetomidine combined with sufentanil in colon cancer resection and its effect on immune and coagulation function of patients. Oncol Lett. 2020; 20(2):1288-94. [DOI:10.3892/ol.2020.11643]
10. Bovill JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJJA. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 1984; 61(5):502-6. [DOI:10.1097/00000542-198411000-00004]
11. Ahonen J, Olkkola KT, Hynynen M, Seppälä T, Ikävalko H, Remmerie B, et al. Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth. 2000; 85(4):533-40. [DOI:10.1093/bja/85.4.533]
12. Pichini S, Solimini R, Berretta P, Pacifici R, Busardò FPJTdm. Acute intoxications and fatalities from illicit fentanyl and analogues: an update. Ther Drug Monit. 2018; 40(1):38-51. [DOI:10.1097/FTD.0000000000000465]
13. Fisher DM, Chang P, Wada DR, Dahan A, Palmer PPJA. Pharmacokinetic properties of a sufentanil sublingual tablet intended to treat acute pain. Anesthesiology. 2018; 128(5):943-52. [DOI:10.1097/ALN.0000000000002145]
14. Bui VD, Son S, Xavier W, Jung JM, Lee J, Shin S, et al. Dissolving microneedles for long-term storage and transdermal delivery of extracellular vesicles. Biomaterials. 2022; 287:121644. [DOI:10.1016/j.biomaterials.2022.121644]
15. Oosten AW, Abrantes JA, Jönsson S, de Bruijn P, Kuip EJ, Falcão A, et al. Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients. Eur J Clin Pharmacol. 2016; 72:459-67. [DOI:10.1007/s00228-015-2005-x]
16. Wang Q, Yang X, Gu X, Wei F, Cao W, Zheng L, et al. Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment. Int J Pharm. 2022; 625:122108. [DOI:10.1016/j.ijpharm.2022.122108]
17. Makvandi P, Jamaledin R, Chen G, Baghbantaraghdari Z, Zare EN, Di Natale C, et al. Stimuli-responsive transdermal microneedle patches. Materials Today. 2021; 47:206-22. [DOI:10.1016/j.mattod.2021.03.012]
18. Ray S, Wirth DM, Ortega-Rivera OA, Steinmetz NF, Pokorski JKJB. Dissolving microneedle delivery of a prophylactic HPV vaccine. Biomacromol 23. 2022; 23(3):903-12. [DOI:10.1021/acs.biomac.1c01345]
19. Paredes AJ, Volpe-Zanutto F, Vora LK, Tekko IA, Permana AD, Picco CJ, et al. Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches. Materials Today Bio. 2022; 13:100217. [DOI:10.1016/j.mtbio.2022.100217]
20. Prausnitz MR, Mitragotri S, Langer RJNrDd. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004; 3(2):115-24. [DOI:10.1038/nrd1304]
21. Damiri F, Kommineni N, Ebhodaghe SO, Bulusu R, Jyothi VGS, Sayed AA, et al. Microneedle-based natural polysaccharide for drug delivery systems (DDS): progress and challenges. Pharmaceuticals. 2022; 15(2):190. [DOI:10.3390/ph15020190]
22. Kim MJ, Seong K-Y, Jeong JS, Kim SY, Lee S, Yang SY, et al. Minoxidil-loaded hyaluronic acid dissolving microneedles to alleviate hair loss in an alopecia animal model. Acta Biomater. 2022; 143:189-202. [DOI:10.1016/j.actbio.2022.02.011]
23. Abdelghany S, Alshaer W, Al Thaher Y, Al Fawares M, Al-Bakri AG, Zuriekat S, et al. Ciprofloxacin-loaded dissolving polymeric microneedles as a potential therapeutic for the treatment of S. aureus skin infections. Beilstein J Nanotechnol. 2022; 13(1):517-27. [DOI:10.3762/bjnano.13.43]
24. Anjani QK, Sabri AHB, Utomo E, Domínguez-Robles J, Donnelly RFJMP. Elucidating the impact of surfactants on the performance of dissolving microneedle array patches. Mol Pharmaceutics. 2022; 19(4):1191-208. [DOI:10.1021/acs.molpharmaceut.1c00988]
25. Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl-and dithienylbutylamines. J Pharmacol Exp Ther. 1953; 107(3):385-93.
26. Malek-Khatabi A, Rad ZF, Rad-Malekshahi M, Akbarijavar H. Development of dissolvable microneedle patches by CNC machining and micromolding for drug delivery. Mater Lett. 2023; 330:133328. [DOI:10.1016/j.matlet.2022.133328]
27. Koh KJ, Liu Y, Lim SH, Loh XJ, Kang L, Lim CY, et al. Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Sci Rep. 2018; 8(1):11842. [DOI:10.1038/s41598-018-30290-3]
28. Safo I, Werheid M, Dosche C, Oezaslan MJNA. The role of polyvinylpyrrolidone (PVP) as a capping and structure-directing agent in the formation of Pt nanocubes. Nanoscale Adv 2019; 1(8):3095-106. [DOI:10.1039/C9NA00186G]
29. Tran L-G, Park W-T. Rapid biodegradable microneedles with allergen reservoir for skin allergy test. Micro and Nano Syst Lett. 2020; 8(11):1-5. [DOI:10.1186/s40486-020-00114-z]
30. Flaten GE, Palac Z, Engesland A, Filipović-Grčić J, Vanić Ž, Škalko-Basnet NJEjops. In vitro skin models as a tool in optimization of drug formulation. 2015; 75:10-24. [DOI:10.1016/j.ejps.2015.02.018]
31. Makvandi P, Kirkby M, Hutton AR, Shabani M, Yiu CK, Baghbantaraghdari Z, et al. Engineering microneedle patches for improved penetration: analysis, skin models and factors affecting needle insertion. Nanomicro Lett. 2021; 13(1):1-41. [DOI:10.1007/s40820-021-00611-9]
32. Czekalla C, Schönborn KH, Lademann J, Meinke MC. Noninvasive determination of epidermal and stratum corneum thickness in vivo using two-photon microscopy and optical coherence tomography: impact of body area, age, and gender. Skin Pharmacol Physiol. 2019; 32(3):142-50. [DOI:10.1159/000497475]
33. Kathuria H, Kang K, Cai J, Kang LJIJoP. Rapid microneedle fabrication by heating and photolithography. Int J Pharm. 2020; 575:118992. [DOI:10.1016/j.ijpharm.2019.118992]
34. Chen M-C, Lin Z-W, Ling M-HJAn. Near-infrared light-activatable microneedle system for treating superficial tumors by combination of chemotherapy and photothermal therapy. ACS nano. 2016; 10(1):93-101. [DOI:10.1021/acsnano.5b05043]
35. Kelchen MN, Siefers KJ, Converse CC, Farley MJ, Holdren GO, Brogden NKJJocr. Micropore closure kinetics are delayed following microneedle insertion in elderly subjects. Journal of controlled release. 2016; 225:294-300. [DOI:10.1016/j.jconrel.2016.01.051]
36. Gupta J, Gill HS, Andrews SN, Prausnitz MRJJocr. Kinetics of skin resealing after insertion of microneedles in human subjects. Journal of controlled release. 2011; 154(2):148-55. [DOI:10.1016/j.jconrel.2011.05.021]
37. Nagra U, Barkat K, Ashraf MU, Shabbir MJD-R. Feasibility of enhancing skin permeability of acyclovir through sterile topical lyophilized wafer on self-dissolving microneedle-treated skin. Dose Response. 2022; 20(2):15593258221097594. [DOI:10.1177/15593258221097594]
38. Chen MC, Lai KY, Ling MH, Lin C-WJAb. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design. Acta biomaterialia. 2018; 65:66-75. [DOI:10.1016/j.actbio.2017.11.004]
39. Zhao X, Li X, Zhang P, Du J, Wang YJJocr. Tip-loaded fast-dissolving microneedle patches for photodynamic therapy of subcutaneous tumor. J Controlled Release. 2018; 286:201-9. [DOI:10.1016/j.jconrel.2018.07.038]
40. Chen MC, Huang SF, Lai KY, Ling MHJB. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. Biomaterials. 2013; 34(12):3077-86. [DOI:10.1016/j.biomaterials.2012.12.041]
41. Chen YH, Lai KY, Chiu YH, Wu YW, Shiau AL, Chen MCJAB. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination. Acta biomaterialia. 2019; 97:230-8. [DOI:10.1016/j.actbio.2019.07.048]
42. Du H, Liu P, Zhu J, Lan J, Li Y, Zhang L, et al. Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces. 2019; 11(46):43588-98. [DOI:10.1021/acsami.9b15668]
43. Xing M, Liu H, Meng F, Ma Y, Zhang S, Gao YJP. Design and evaluation of complex polypeptide-loaded dissolving microneedles for improving facial wrinkles in different areas. Polymers. 2022; 14(21):4475. [DOI:10.3390/polym14214475]
44. Elim D, Fitri AMN, Mahfud MASb, Afika N, Sultan NAF, Asri RM, et al. Hydrogel forming microneedle-mediated transdermal delivery of sildenafil citrate from polyethylene glycol reservoir: An ex vivo proof of concept study. Colloids Surf B Biointerfaces. 2023; 222:113018. [DOI:10.1016/j.colsurfb.2022.113018]
45. Chen Y, Yang Y, Xian Y, Singh P, Feng J, Cui S, et al. Multifunctional graphene-oxide-reinforced dissolvable polymeric microneedles for transdermal drug delivery. ACS Appl Mater Interfaces. 2019; 12(1):352-60. [DOI:10.1021/acsami.9b19518]
46. Ramöller IK, Tekko IA, McCarthy HO, Donnelly RFJIJoP. Rapidly dissolving bilayer microneedle arrays-a minimally invasive transdermal drug delivery system for vitamin B12. Int J Pharm. 2019; 566:299-306. [DOI:10.1016/j.ijpharm.2019.05.066]
47. Duan X, Ma J, Ning M, Gao Y. Dissolving Microneedles Loaded with Gestodene: Fabrication and characterization In vitro and in vivo. Iran J Pharm Res. 2023; 22(1):e131819. [DOI:10.5812/ijpr-131819]
48. Fisher DM, Kellett N, Lenhardt RJTJotASoA. Pharmacokinetics of an implanted osmotic pump delivering sufentanil for the treatment of chronic pain. Anesthesiology. 2003; 99(4):929-37. [DOI:10.1097/00000542-200310000-00028]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |